Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-17-000002

Options or other derivatives

  • VP Clinical Research & Operati acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Feldman Maria · VP Clinical Research & Operati

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-03-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X03/primary_doc.xml…